PATRYS LIMITED
ASX:PABPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 76.4% of what they think they own, once every option and right converts.
Share count grew 328% in 24 months; runway 2–4 quarters; 5 cash raises in 24 months
Between June 2025 and July 2026, PATRYS LIMITED's latest share-count filing, its ordinary share count increased 327.9%, adjusted for a 1-for-15 share consolidation completed in October 2025; the adjusted latest count stands at 675M shares. The company raised capital five times in that period for total disclosed proceeds of A$9.1M, most recently a placement in June 2026. Options and rights could convert into 209M new shares, representing a 30.9% dilution overhang, with 13% in the money; the nearest expiry is February 2029. The company has 2 to 4 quarters of funding at the recent spend rate. No proposed securities issues are pending.
Quick answers · 3
How much placement capacity does PAB have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does PAB have?
In its quarterly cash report for the quarter ended 30 June 2026, Patrys reported $3.4M of cash and estimated 4.3 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do PAB's options expire?
Unexercised options and rights equal 30.9% of Patrys's shares on issue; the nearest expiry is Feb 2029.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 30 Sept 2026 | 3H · cancellation | PAB : ORDINARY FULLY PAID | 674.8M | Appendix 3H |
| 15 July 2026 | 2A · quoted issue | PAB : ORDINARY FULLY PAID | 674.8M | Appendix 2A |
| 15 July 2026 | 3G · unquoted | PAB : ORDINARY FULLY PAID | 673.3M | Appendix 3G |
| 3 July 2026 | 2A · quoted issue | PAB : ORDINARY FULLY PAID | 673.3M | Appendix 2A |
| 3 July 2026 | 3G · unquoted | PAB : ORDINARY FULLY PAID | 666.6M | Appendix 3G |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
5 cash raises in the last 24 months · 2 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered138.9M · 20.6% of sharesOptions and warrants — they convert when the share price clears their exercise price.
- Condition-triggered70.0M · 10.4% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 138.9M priced (of which 90.1M in the money), 70.0M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
At $0.025 today, 90.1M securities are in the money (13.4% of shares on issue). At double today’s price it is 138.9M (20.6% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 70.0M (33.5% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| PABAD | Options | Price-triggered | $0.040 | 10 Feb 2029 | 5.0M | Filing |
| PABAB | Options | Price-triggered | $0.024 | 30 Nov 2029 | 90.1M | Filing |
| PABAE | Options | Price-triggered | $0.048 | 30 Nov 2030 | 43.7M | Filing |
| PABAC | Performance rights | Condition-triggered | — | — | 70.0M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 3 July 2026 | Anton Uvarov | Buy placement | 2.1M | 521k | — | $50k | 3Y notice |
| 3 July 2026 | Dino Cercarelli | Buy placement | 1.3M | 313k | — | $30k | 3Y notice |
| 3 July 2026 | Leanne Kite | Buy placement | 2.1M | 521k | 10.0M | $50k | 3Y notice |
| 3 July 2026 | Peter Christie | Buy placement | 1.3M | 313k | — | $30k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.